nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biochemical testing to differentiate Cushing’s disease from ectopic ACTH syndrome
|
Ferriere, Amandine |
|
|
25 |
5 |
p. 705-708 |
artikel |
2 |
Cardiovascular health and mortality in Cushing’s disease
|
Coulden, Amy |
|
|
25 |
5 |
p. 750-753 |
artikel |
3 |
Cushing’s disease: adrenal steroidogenesis inhibitors
|
Pivonello, Rosario |
|
|
25 |
5 |
p. 726-732 |
artikel |
4 |
Cushing’s disease in children: unique features and update on genetics
|
Stratakis, Constantine A. |
|
|
25 |
5 |
p. 764-767 |
artikel |
5 |
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation
|
Balomenaki, Maria |
|
|
25 |
5 |
p. 718-721 |
artikel |
6 |
Cushing’s disease: role of bilateral adrenalectomy
|
Bertherat, Jérôme |
|
|
25 |
5 |
p. 743-745 |
artikel |
7 |
Cushing’s disease: role of preoperative and primary medical therapy
|
Castinetti, Frederic |
|
|
25 |
5 |
p. 737-739 |
artikel |
8 |
Genetics of Cushing’s disease: from the lab to clinical practice
|
Theodoropoulou, Marily |
|
|
25 |
5 |
p. 689-692 |
artikel |
9 |
Glucocorticoid receptor blockers
|
Molitch, Mark E. |
|
|
25 |
5 |
p. 733-736 |
artikel |
10 |
Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease
|
Boguszewski, Cesar Luiz |
|
|
25 |
5 |
p. 760-763 |
artikel |
11 |
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)
|
Scaroni, Carla |
|
|
25 |
5 |
p. 701-704 |
artikel |
12 |
Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
|
Feelders, Richard A. |
|
|
25 |
5 |
p. 746-749 |
artikel |
13 |
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)
|
Raff, Hershel |
|
|
25 |
5 |
p. 698-700 |
artikel |
14 |
Modern imaging in Cushing’s disease
|
Bashari, W. A. |
|
|
25 |
5 |
p. 709-712 |
artikel |
15 |
Novel approaches to bone comorbidity in Cushing’s disease: an update
|
Frara, Stefano |
|
|
25 |
5 |
p. 754-759 |
artikel |
16 |
Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome
|
Petersenn, Stephan |
|
|
25 |
5 |
p. 693-697 |
artikel |
17 |
Pituitary acting drugs: cabergoline and pasireotide
|
Gadelha, Mônica R. |
|
|
25 |
5 |
p. 722-725 |
artikel |
18 |
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation
|
Jones, Pamela S. |
|
|
25 |
5 |
p. 713-717 |
artikel |
19 |
Pituitary tumor centers of excellence for Cushing’s disease
|
Couselo, Marcos |
|
|
25 |
5 |
p. 772-775 |
artikel |
20 |
Quality of life impairment after a diagnosis of Cushing’s syndrome
|
Webb, Susan M |
|
|
25 |
5 |
p. 768-771 |
artikel |
21 |
Role of Radiation in the treatment of Cushing Disease
|
Katznelson, Laurence |
|
|
25 |
5 |
p. 740-742 |
artikel |
22 |
Special issue: Cushing's disease update
|
Fleseriu, Maria |
|
|
25 |
5 |
p. 687-688 |
artikel |